Benzinga | Aug 6, 2020 05:43PM EDT

Theravance Biopharma Q2 EPS $(1.00) Misses $0.98 Estimate, Sales $15.01M Miss $19.64M Estimate

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $0.98 by 202.04 percent. This is a 38.89 percent decrease over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $15.01 million which missed the analyst consensus estimate of $19.64 million by 23.58 percent. This is a 42.61 percent decrease over sales of $26.15 million the same period last year.